Conditions: Epilepsies Partial
Keywords: Epilepsies Partial Keppra levetiracetam
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 398
Healthy volunteers: no

Brief summary:
This study is planned to evaluate the safety and efficacy of L059 (levetiracetam) in long-term administration in patients who completed N01020 \[NCT00160165\] or N01221 \[NCT00280696\].

Detailed description:

Arms:
arm 1: Levetiracetam 500 mg/day to 3000 mg/day , tablets twice daily (morning and evening orally) during the study period (until the time of approval granted).

Interventions: intervention 1: Levetiracetam
Intervention descriptions: intervention 1: Levetiracetam 500 mg/day to 3000 mg/day , tablets twice daily (morning and evening orally) during the study period (until the time of approval granted).

Protocol document: